Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
News | Heart Failure | November 07, 2018
November 6, 2018 – Initial results from the real-world EMPagliflozin compaRative effectIveness and SafEty (EMPRISE)...
News | Heart Failure | November 02, 2018
November 2, 2018 — In a new study, acute heart failure patients who received individualized treatment by blood volume...
CHF Solutions' Aquadex FlexFlow System
News | Heart Failure | November 01, 2018
November 1, 2018 — Daxor Corp. has entered an agreement with CHF Solutions to explore clinical synergies between Daxor’...
News | Heart Failure | October 29, 2018
October 29, 2018 — The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, is...
A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.
Feature | Heart Failure | October 19, 2018
October 19, 2018 — Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U.S....
An example of the new transesophageal echo (TEE) visualization technology called TrueVue was shown at TCT 2018 for the first time. Philips’ new photo-realistic rendering is designed to offer a surgical view of cardiac structures to aid transcatheter procedural navigation. The technology also allows the lighting source to be moved around and even behind the anatomy, as demonstrated here. This video, included as part of the most innovative technologies video at TCT 2018, went viral when posted on social media during TCT 2018, and was viewed more than 167,000 times.
Blog | TCT | October 15, 2018
From a cardiovascular device innovation standpoint, the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference...
Videos | October 11, 2018
A discussion with Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president,...
News | Heart Failure | October 04, 2018
October 4, 2018 — The Ohio State University Wexner Medical Center is first in the country to test a new medical device...
Simon Stertzer, M.D., is one of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s and 1980s. He performed the first coronary balloon angioplasty in the United States in 1978.
Feature | October 03, 2018
One of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s was Simon...
News | Heart Failure | September 28, 2018
September 28, 2018 — Heart failure patients who received the Carillon Mitral Contour System in the REDUCE FMR clinical...
Videos | Heart Failure | September 26, 2018
William Abraham, M.D., FACC, professor of medicine and director of the division of cardiovascular medicine, The Ohio...
News | Heart Valve Technology | September 26, 2018
September 26, 2018 — Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic...
News | Heart Valve Technology | September 24, 2018
September 24, 2018 — Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early...
News | Heart Failure | September 20, 2018
September 20, 2018 — Cardiac Dimensions announced the company has randomized its first patient in the CARILLON Pivotal...
News | Heart Failure | September 07, 2018
September 7, 2018 — The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival,...
